by Julie Manz | Sep 27, 2025 | The Doctor's Dose
Conquering FOMO in Trading: A Performance Psychology Perspective Conquering FOMO is one of the biggest challenges traders face on their path to consistent performance. Fear of Missing Out (FOMO) can appear as a simple emotional nudge, but research in performance...
by ADRIAN MANZ | Sep 27, 2025 | The Doctor's Dose
Nvidia AI Backstop: How $100 Billion Fuels the Next Leg of the Boom TraderInsight • September 2025 • NVDA, AI, Circular Financing Nvidia has turned its free cash flow machine into a war chest for AI. By acting as an Nvidia AI backstop, the company is funneling...
by ADRIAN MANZ | Sep 26, 2025 | The Doctor's Dose
AstraZeneca Drug Discounts Show Pharma’s Response to Trump’s Pressure TraderInsight • September 26, 2025 • Pharma, Pricing, Policy With a Trump administration deadline looming, AstraZeneca announced it will cut prices on key asthma and diabetes drugs by as much as...
by ADRIAN MANZ | Sep 25, 2025 | The Doctor's Dose
Drug Pricing Uncertainty Keeps a Lid on Pharma Stocks TraderInsight • September 2025 • Pharma, Tariffs, Policy The Trump administration’s 100% tariffs on foreign-made drugs sounded harsh. In reality, Big Pharma can live with them. What the sector can’t shake is drug...
by ADRIAN MANZ | Sep 24, 2025 | The Doctor's Dose
Perpetual Futures Trading: Why ‘Perps’ Are Driving a New Speculation Boom TraderInsight • September 2025 • Crypto, Leverage, Derivatives Crypto traders are rushing into perpetual futures trading, contracts known as “perps” that allow investors to apply leverage of 10,...
by admin | Sep 24, 2025 | The Doctor's Dose
Day Trading Margin Rule Change: What It Means for Retail Traders TraderInsight • September 24, 2025 • FINRA, SEC, PDT For over two decades, retail traders have been operating under the shadow of the Pattern Day Trader rule. If your account dropped below $25,000, you...
by ADRIAN MANZ | Sep 24, 2025 | The Doctor's Dose
Alibaba AI Spending Rally: Why the Stock Could Climb Even Higher TraderInsight • September 24, 2025 • BABA, AI, China Tech Alibaba (BABA) shares jumped 10% after the company announced new AI spending, overseas data centers, and the unveiling of Qwen3-Max, its...
by ADRIAN MANZ | Sep 24, 2025 | The Doctor's Dose
Nvidia AI Backstop: Trader’s Playbook for the AI Ecosystem TraderInsight • September 2025 • NVDA, AI Infrastructure, Market Strategy Nvidia’s $100 billion deal with OpenAI reinforces its role as the Nvidia AI backstop — a financing partner to secure chip demand and...
by ADRIAN MANZ | Sep 23, 2025 | The Doctor's Dose
Is the Stock Market Overvalued? What Traders Should Watch Next TraderInsight • September 22, 2025 • S&P 500, Fed, Valuations The S&P 500 has set 28 record highs this year and sits near 6,664. But valuations are stretched to dot-com era levels, making many...
by ADRIAN MANZ | Sep 23, 2025 | The Doctor's Dose
Powell Speech Market Selloff: Why Stocks Dropped After Fed Remarks TraderInsight • Today • Federal Reserve, Markets, Equities Stocks fell sharply today after Federal Reserve Chairman Jerome Powell delivered a speech that rattled investor confidence. The Powell speech...
